2008 - Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease

Farkouh, Michael E.
January 2009
ACP Journal Club;1/1/2009, Vol. 150 Issue 1, p6
Academic Journal
The article focuses on a study titled "The prevention of progression of arterial disease and diabetes trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease," by researcher J. Belch and colleagues. It found that in patients with diabetes and asymptomatic peripheral arterial disease, aspirin and antioxidants did not reduce risk for cardiovascular events.


Related Articles

  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. Belch, Jill; MacCuish, Angus; Campbell, Iain; Cobbe, Stuart; Taylor, Roy; Prescott, Robin; Lee, Robert; Bancroft, Jean; MacEwan, Shirley; Shepherd, James; Macfarlane, Peter; Morris, Andrew; Jung, Roland; Kelly, Christopher; Connacher, Alan; Peden, Norman; Jamieson, Andrew; Matthews, David; Leese, Graeme; McKnight, John // BMJ: British Medical Journal (International Edition);11/1/2008, Vol. 337 Issue 7677, p1030 

    Objective To determine whether aspirin and antioxidant therapy, combined or alone, are more effective than placebo in reducing the development of cardiovascular events in patients with diabetes mellitus and asymptomatic peripheral arterial disease. Design Multicentre, randomised, double blind,...

  • Improvement of Diabetic Microangiopathy With Pycnogenol: A Prospective, Controlled Study. Cesarone, M. R.; Belcaro, G.; Rohdewald, P.; Pellegrini, L.; Ledda, A.; Vinciguerra, G.; Ricci, A.; Gizzi, G.; Ippolito, E.; Fano, F.; Dugall, M.; Cipollone, G.; Acerbi, G.; Cacchio, M.; Del Boccio, G.; Di Renzo, A.; Stuard, S.; Corsi, M. // Angiology;Aug/Sep2006, Vol. 57 Issue 4, p431 

    The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd, United Kingdom) in patients with diabetic microangiopathy. Patients without a history of diabetic ulcerations were treated with Pycnogenol, Patients received oral Pycnogenol (50 mg...

  • Screening for diabetes on a vascular ward: lessons from an audit. Stuart, W.P.; Wolf, B.; Macaulay, E.M.; Cross, K.S. // Journal of the Royal College of Surgeons of Edinburgh;Feb98, Vol. 43 Issue 1, p11 

    Examines the effectiveness of the random plasma glucose testing in screening patients with peripheral arterial disease for diabetes. Correlation between diabetes and atherosclerosis; Controversies over the role and value of population screening; Prevalence of diabetes mellitus.

  • Inverse Association between Serum Bilirubin Levels and Arterial Stiffness in Korean Women with Type 2 Diabetes. Kim, Eun Sook; Mo, Eun young; Moon, Sung Dae; Han, Je Ho // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Considerable evidence suggests that bilirubin is a potent physiologic antioxidant that may provide important protection against cardiovascular disease (CVD) and inflammation. We investigated the relationship between serum total bilirubin (TB) levels and arterial stiffness, measured...

  • Carotid artery thickening demonstrates elevated CAD risk with diabetes.  // Geriatrics;Sep2000, Vol. 55 Issue 9, p29 

    Provides information on a study which compared the thickness of the common carotid artery (CCA) and internal carotid artery (ICA) in diabetic and nondiabetic patients. Thickness of CCA and ICA in patients with coronary artery disease; Differences in the dimensions of the ICA; Risk factors for...

  • Top picks.  // Endocrine Today;May2011, Vol. 9 Issue 5, p54 

    A list of the most popular articles available on EndocrineToday.com as of April 2011 is presented, including "Aspirin Use in Patients With Diabetes Requires Careful Consideration," and "Stem Cells May Hold Key to Reversing Diabetes."

  • Aspirin Cuts Death Risk In Diabetics.  // Renal & Urology News;Jan2010, Vol. 9 Issue 1, p18 

    The article reports that regular use of aspirin may decrease the risk of death in diabetic patients.

  • Picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial disease: COMMENTARY. Smith, Donald A. // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p61 

    This article comments on the effect of picotamide in type 2 diabetes mellitus and peripheral arterial disease. The 24-month DAVID study by Neri Serneri and colleagues compared picotamide with daily aspirin in patients with type 2 diabetes and PAD, and showed a decreased risk for all-cause...

  • Picotamide likely cost effective vs aspirin for preventing CV events.  // PharmacoEconomics & Outcomes News;1/27/2007, Issue 520, p8 

    The article reports on the cost effectiveness of picotamide in preventing cardiovascular events among patient with diabetes and peripheral arterial disease. According to study conducted by researchers from Italy, they created a Markov model to determine the cost effectiveness of lifetime...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics